UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000062141
Receipt number R000071112
Scientific Title Non-clinical performance evaluation of a novel respiratory support device integrating high-flow nasal cannula and CPAP using a 3D-printed airway model and a TTL lung model: a bench study
Date of disclosure of the study information 2026/07/06
Last modified on 2026/07/05 22:21:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Bench evaluation of a novel respiratory support device combining high-flow nasal cannula and CPAP

Acronym

HFNC-P Bench Study

Scientific Title

Non-clinical performance evaluation of a novel respiratory support device integrating high-flow nasal cannula and CPAP using a 3D-printed airway model and a TTL lung model: a bench study

Scientific Title:Acronym

HFNC-P Bench Study

Region

Japan


Condition

Condition

None

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to evaluate the performance of HFNC-P, a novel respiratory support device that integrates high-flow nasal cannula and CPAP, through bench experiments using a 3D-printed airway model and a TTL lung model.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Phase I


Assessment

Primary outcomes

measured intratracheal PEEP

Key secondary outcomes

Difference between the set PEEP and the measured intratracheal PEEP
ETCO2 or PETCO2
Reduction in ETCO2 or PETCO2 from baseline
Mask pressure
Difference between intratracheal pressure and mask pressure
Mean PEEP
Minimum PEEP
Maximum PEEP
PEEP maintenance rate
Pressure drop during the inspiratory phase
Stability of the pressure waveform
Degree of PEEP increase associated with changes in flow rate
Degree of ETCO2 or PETCO2 reduction associated with changes in flow rate
FiO2 maintenance effect
Amount or presence of leakage
Humidification effect
Temperature inside the mask
Relative humidity or absolute humidity
Presence or absence of condensation or water droplet accumulation
Stability of CO2 supply
Stability of the ETCO2 waveform
Operation status of the safety valve or one-way valve
Pressure changes under abnormal conditions, such as obstruction, overpressure, or flow interruption
Performance differences between controlled ventilation and spontaneous breathing models
Performance differences among normal, restrictive, and obstructive lung models


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Not applicable

Key exclusion criteria

Not applicable

Target sample size

0


Research contact person

Name of lead principal investigator

1st name Ryuto
Middle name
Last name Yokoyama

Organization

Yamagata University Faculty of Medicine

Division name

Department of Emergency Medicine

Zip code

990-9585

Address

2-2-2 Iida Nishi, Yamagata City, Yamagata Prefecture

TEL

0236331122

Email

ryusi0311@gmail.com


Public contact

Name of contact person

1st name RYUTO
Middle name
Last name YOKOYAMA

Organization

Yamagata University Faculty of Medicine

Division name

Department of Emergency Medicine

Zip code

9909585

Address

2-2-2 Iida Nishi, Yamagata City, Yamagata Prefecture

TEL

0236285422

Homepage URL


Email

ryusi0311@gmail.com


Sponsor or person

Institute

Yamagata Univercity

Institute

Department

Personal name

RYUTO YOKOYAMA


Funding Source

Organization

Yamagata Univercity

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Review Committee, Faculty of Medicine, Yamagata University

Address

2-2-2 Iida Nishi, Yamagata City, Yamagata Prefecture

Tel

0236331122

Email

ryusi0311@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 07 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 07 Month 01 Day

Date of IRB

2026 Year 07 Month 03 Day

Anticipated trial start date

2026 Year 07 Month 06 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study is a non-clinical bench study with no human participants enrolled. The performance of a novel respiratory support device integrating high-flow nasal cannula and CPAP will be evaluated using a 3D-printed airway model and a TTL lung model. The investigational prototype will not be applied to or used in patients or healthy volunteers. The results of this study will not directly demonstrate efficacy or safety in humans, but will serve as preclinical performance data to support future first-in-human and patient-based clinical studies.


Management information

Registered date

2026 Year 07 Month 05 Day

Last modified on

2026 Year 07 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000071112